Madrigal Pharmaceuticals
MDGL
MDGL
75 hedge funds and large institutions have $16.3M invested in Madrigal Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
86% less capital invested
Capital invested by funds: $119M → $16.3M (-$103M)
Holders
75
Holding in Top 10
1
Calls
$79K
Puts
$130K
Top Buyers
| 1 | +$881K | |
| 2 | +$428K | |
| 3 | +$348K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$312K |
| 5 |
Goldman Sachs
New York
|
+$284K |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$5.41M | |
| 3 | -$3.48M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.15M |
| 5 |
IIM
Ironwood Investment Management
Boston,
Massachusetts
|
-$752K |